Finance

Beta
Lists
3353:TYO
Medical Ikkou Group Co Ltd
¥2,747.00
+0.96%
(+26.00) 1D
May 29, 3:00:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3353...
Open
¥2,750
High
¥2,750
Low
¥2,747
Mkt. cap
10.36B
Avg. vol.
2.16K
Volume
1.20K
Dividend
4.37%
Quarterly dividend
¥30
Ex-dividend date
Feb 26, 2026
P/E ratio
8.11
52-wk high
¥4,410
52-wk low
¥2,320
EPS
¥339
Shares outstanding
1.92M
No. of employees
2K
Open
¥2,750
High
¥2,750
Low
¥2,747
Mkt. cap
10.36B
Avg. vol.
2.16K
Volume
1.20K
Dividend
4.37%
Quarterly dividend
¥30
Ex-dividend date
Feb 26, 2026
P/E ratio
8.11
52-wk high
¥4,410
52-wk low
¥2,320
EPS
¥339
Shares outstanding
1.92M
No. of employees
2K
News stories
From sources across the web
About Medical Ikkou Group Co Ltd
CEO-
Employees1.61K
Founded1980
HeadquartersTsu, Mie, Japan
SectorDrug
Websitem-ikkou.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
13.42B
13.51B
13.93B
14.11B
Cost of goods sold
11.85B
11.97B
12.25B
12.42B
Cost of revenue
11.85B
11.97B
12.25B
12.42B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14B
1.23B
1.20B
1.13B
Operating expense
1.14B
1.23B
1.20B
1.13B
Total operating expenses
12.99B
13.20B
13.45B
13.55B
Operating income
435.00M
309.00M
484.00M
560.00M
Other non operating income
74.00M
56.00M
24.00M
19.00M
EBT including unusual items
665.00M
370.00M
483.00M
506.00M
EBT excluding unusual items
501.00M
381.00M
491.00M
586.00M
Income tax expense
212.00M
133.00M
192.00M
173.00M
Effective tax rate
31.88%
35.95%
39.75%
34.19%
Other operating expenses
-
-
-
-
Net income
438.00M
228.00M
280.00M
329.00M
Net profit margin
3.26%
1.69%
2.01%
2.33%
Earnings per share
-
-
-
-
Interest and investment income
13.00M
41.00M
11.00M
35.00M
Interest expense
-21.00M
-25.00M
-28.00M
-28.00M
Net interest expenses
-8.00M
16.00M
-17.00M
7.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
625.50M
509.50M
674.50M
770.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer